ORIX CORP ORXCF
OTC · OOTC · stock · Miscellaneous Business Credit Institution
7/9
Piotroski F — financial health
—
Altman Z″ — distress risk
38.2%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2026 | $3.33T | $447.3B | — | — | $4.48T |
| 2025 | $2.87T | $351.6B | — | — | $4.09T |
| 2024 | $2.81T | $346.1B | — | — | $4.02T |
| 2023 | $1.30T | $290.3B | — | — | $3.61T |
| 2022 | $2.51T | $317.4B | — | — | $3.41T |
| 2021 | $1.09T | $192.4B | — | — | $3.10T |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Otsuka Takashi | See Remarks | 2026-05-20 | Buy | 13 | $38.22 |
| Matsuzaki Satoru | See remarks | 2026-05-20 | Buy | 7 | $38.22 |
| Ishihara Tomohiko | Executive Officer | 2026-05-20 | Buy | 4 | $38.22 |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0001070304 · as of 2026-03-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.